Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

User: Guest

Title:: Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer
Document type:: Zeitschriftenaufsatz
Author(s):: Althoff, Friederike C. ; Schäfer, Lisa V. ; Acker, Fabian ; Aguinarte, Lukas ; Heinzen, Sophie ; Rost, Maximilian ; Atmaca, Akin ; Rosery, Vivian ; Alt, Jürgen ; Waller, Cornelius F. ; Reinmuth, Niels ; Rohde, Gernot ; Saalfeld, Felix C. ; Becker von Rose, Aaron ; Möller, Miriam ; Frost, Nikolaj ; Sebastian, Martin ; Stratmann, Jan A.
Keywords:: Oncology ; small cell lung cancer ; recurrent disease ; metastatic disease ; brain metastases ; systemic treatment ; checkpoint inhibitors ; brain irradiation
Journal title:: Frontiers in Oncology
Year:: 2023
Journal volume:: 13
Fulltext / DOI:: doi:10.3389/fonc.2023.1273478
Publisher:: Frontiers Media S.A.
E-ISSN:: 2234-943X
Date of publication:: 22.09.2023
CC license:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Occurrences: